Peter Buhl

Board of Directors, SYMBION FONDEN

Houvej 101DK9 active roles

Peter Buhl is a Danish director with 9 active roles across Danish companies, including Board of Directors at SYMBION FONDEN.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

in directorship history

2025 – now
Unofficial title, Farum Sogn
2024 – now
Board of Directors, AÏDA ONCOLOGY Aps
2023 – now
Chief Executive Officer, RHOVAC ApS
2022 – now
Chief Executive Officer, Chosa ApS
2019 – now
Board of Directors, Symbion Frederiksberg A/S
2017 – 2018
Board of Directors, Ranger Biotechnologies A/S
2017 – 2018
Chairman, Allarity Therapeutics Denmark ApS
2014 – 2017
Board of Directors, ACCELERACE MANAGEMENT A/S
2013 – 2014
Board of Directors, IT-VÆKSTHUS A/S
2012 – now
Board of Directors, GROSSERER SIGURD ABRAHAMSON OG HUSTRU ADDIE ABRAHAMSONS MINDELEGAT
2012 – 2019
Board of Directors, Allarity Therapeutics A/S
2012 – 2019
Management, Allarity Therapeutics Europe ApS
2012 – 2018
Board of Directors, VECATA INVEST ApS
2012 – 2013
Board of Directors, Renovaro Biosciences Denmark ApS
2010 – now
Board of Directors, SYMBION A/S
2010 – 2014
Board of Directors, SYMBION MANAGEMENT A/S
2009 – 2010
Chairman, CYTOGUIDE ApS
2008 – 2018
Board of Directors, 4 BEST INVEST ApS
2008 – 2016
Board of Directors, LIPLASOME PHARMA ApS
2008 – 2012
Board of Directors, Bagger-Sørensen Real Estate A/S
2008 – 2010
Deputy Chairman, UDVIKLINGSSELSKABET LP AF 11. JANUAR 2001 A/S
2007 – 2010
Board of Directors, MEDICON VALLEY ALLIANCE F.M.B.A.
2005 – now
Board of Directors, SYMBION FONDEN
2000 – now
Founder, BUHL KRONE HOLDING ApS
2000 – 2015
Founder, ANTIANTHRA ApS
2000 – 2010
Management, TOPOTARGET A/S

Nationality

Address

Houvej 101